Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 36 Toxicology PhD Projects, Programmes & Scholarships for UK Students

Discipline

Discipline

Medicine

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a UK student


Toxicology PhD Projects, Programmes & Scholarships for UK Students

We have 36 Toxicology PhD Projects, Programmes & Scholarships for UK Students

A PhD in Toxicology involves in-depth research to the effect of different chemicals on the health of organisms, especially humans. You could be investigating the impact of these toxins or focus on finding treatments for them.

What’s it like to study a PhD in Toxicology?

If you’re planning on studying a PhD In Toxicology, you could be monitoring how different toxins affect the health and wellbeing of humans or carry out assessments for risks to public health. A PhD in Toxicology is a highly interdisciplinary subject and you’ll be required to interact with concepts from other STEM fields like Biology, Chemistry, Medicine or Pharmacy.

Some popular Toxicology research topics are

  • Cellular signalling
  • Cell damage
  • Cell death
  • Aquatic toxicology
  • Medical toxicology
  • Forensic toxicology

At the end of your PhD, you will have produced a unique piece of research which has significant impact in your field. You will be required to submit an 80,000-word thesis to be defended in an oral viva examination.

Like other STEM subjects, PhDs in Toxicology are advertised with a research aim attached. Some universities are open to applicants proposing their own research, however, we highly recommend that you talk to a potential supervisor about the scope of your research before you make a formal application.

In the UK, you might have to apply into an MPhil programme to begin with, however, you can upgrade to a PhD once your supervisor is convinced that your work meets certain expectations

Some elements of a Toxicology PhD call for laboratory rotations and teaching modules that are meant to equip you with certain transferable skills. You might be asked to take these classes in the first year of your study.

Entry requirements

To be able to do a PhD in Toxicology, an application must hold an Upper Second Class Bachelors degree in a relevant subject like Biology or Medicine. In some cases, a Lower Second-Class degree will also be accepted if you also hold a Masters with at least a Merit qualification.

Depending on where you study, you might also have to submit language test results to show that you’ll understand the course content.

PhD in Toxicology funding options

In the UK, a PhD in Toxicology is funded by the Medical Research Council (MRC). They offer fully funded studentships along with a monthly stipend. If you’re applying for a PhD with funding already attached, you’ll get guaranteed funding if you’re successful in your application. If you’re proposing your own project, you’ll have to be accepted into a university and then apply for funding separately.

PhD in Toxicology careers

Toxicology doctoral graduates usually go on to work in forensics, healthcare, pharmaceuticals and governments. If you wish to continue your research, you can think of working as a postdoctoral research fellow or in academia.

read more

Develop rapid, easy to use and cost-effective tests for tropane-alkaloids in food (36 months)

We are inviting applications from highly motivated individuals for a three-year PhD studentship in a multidisciplinary field. The focus of this opportunity is the development of rapid, user-friendly, and cost-effective tests for tropane-alkaloids (TAs) in food. Read more

HORIZON EUROPE MSCA DOCTORAL NETWORK “MELOMANES”

Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies (chemotherapy, radiotherapy) that have a limited efficacy. Read more

Unravelling mechanisms of drug-induced myocarditis using human cardiovascular-chip models integrated with immune cells

The 4-year PhD project aims to address an important and challenging knowledge gap concerning new therapeutic modalities, such as monoclonal antibodies and cell therapies, that can potentially induce cardiac toxicity in the clinic (i.e., inflammatory cardiomyopathy and myocarditis). Read more

Elucidating the fate of iron and copper based nanofertilizer in soil-plant system using isotope labelling and synchrotron techniques

Nanotechnology is a rapidly advancing enabling technology with the potential to revolutionize modern life. More recently, the application of nanotechnology in agriculture has garnered significant attention due to its high potential to facilitate sustainable agriculture and enhance food security. Read more

How does Clostridium perfringens colonise the human intestine?

Clostridium perfringens is a strictly anaerobic pathogen that produces a large number of different toxins. It causes a variety of intestinal diseases which are particularly lethal in very young infants. Read more

New disease prevention strategies targeting BK polyomavirus infection informed by whole-genome CRISPR-knockout screening and/or apical extrusion.

BK virus is a ubiquitous childhood infection that persists in the kidney throughout adult life. BK virus reactivation under immunosuppression is responsible for one third of kidney transplant failures and a three-fold greater risk of bladder cancer in kidney transplant recipients. Read more

10+ fully funded PhD positions at the IMPRS for Molecular Organ Biology

10+ fully funded PhD positions at the IMPRS for Molecular Organ Biology. PhD Studies in the Heart of Europe. The International Max Planck Research School for Molecular Organ Biology (IMPRS-MOB) offers fully funded positions to talented and enthusiastic students holding a relevant Master‘s degree. Read more

A 3D human muscle model for sarcopenia research

Sarcopenia is an age-related disease characterised by a progressive loss of muscle mass and strength.  It is estimated to affect 5.3% of the UK population costing the NHS and has no cure. Read more

Filtering Results